Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study

Virtually no clinical trials for smoking cessation have been undertaken in bipolar disorder. Varenicline has shown efficacy for smoking cessation, but warnings about neuropsychiatric adverse events have been issued. We assessed the efficacy and safety of varenicline in euthymic bipolar subjects moti...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	The journal of clinical psychiatry Ročník 75; číslo 7; s. 765
Hlavní autoři:	Chengappa, K N Roy, Perkins, Kenneth A, Brar, Jaspreet S, Schlicht, Patricia J, Turkin, Scott R, Hetrick, Michelle L, Levine, Michele D, George, Tony P
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.07.2014
Témata:	Adult Benzazepines - administration & dosage Benzazepines - adverse effects Benzazepines - pharmacology Bipolar Disorder - drug therapy Bipolar Disorder - epidemiology Comorbidity Double-Blind Method Female Humans Male Middle Aged Nicotinic Agonists - administration & dosage Nicotinic Agonists - adverse effects Nicotinic Agonists - pharmacology Quinoxalines - administration & dosage Quinoxalines - adverse effects Quinoxalines - pharmacology Smoking - drug therapy Smoking - epidemiology Smoking Cessation - methods Treatment Outcome Varenicline
ISSN:	1555-2101, 1555-2101
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!